跳至主要内容
临床试验/NCT01536470
NCT01536470已完成4 期

Effectiveness of Noradrenaline to Control Intraoperative Arterial Pressure in High-risk Surgical Patients: A Multicentre Prospective Randomized Controlled Trial

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2012年3月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
Composite endpoint of postoperative SIRS and at least one major organ dysfunction

研究概览

简要总结

The purpose of this study is to evaluate whether a preventive strategy of intraoperative arterial hypotension using noradrenaline can reduce the incidence of postoperative organ failure.

详细描述

The maintenance of arterial blood pressure is essential for organ perfusion pressure. Intraoperative hypotension is a frequent complication both after induction and during maintenance of anaesthesia, ranging from 5% to 75% depending on the chosen definition. Tissue hypoperfusion exposes to the occurrence of a systemic inflammatory response syndrome and is a key determinant of postoperative complications. Persistent intraoperative hypotension has been reported as an important prognostic factor of postoperative morbidity and mortality. Adequate treatment of arterial hypotension is therefore of particular importance during surgery, but optimal strategy of intraoperative blood pressure management remains undetermined, especially in high-risk patients. Target ranges for arterial pressure are not clearly defined, and hypotension is usually defined as a systolic pressure of less than 80 mmHg or a decrease of more than 40% from baseline.

Traditionally, management of intraoperative hypotension consisted primarily of fluid administration whereas vasoconstrictors, such as Ephedrine chlorhydrate, are often used as a second line therapy. This may, however, expose patients to prolonged hypotension and to excessive fluid administration, and each of them may alter tissue oxygenation.

Recent experimental data have shown that noradrenaline, which has - and -adrenergic effects, has no detrimental effects on microcirculatory blood flow and tissue oxygenation in the intestinal tract. Because of anaesthesia-induced vasodilatation, the use of a continuous infusion of noradrenaline to increase systemic vascular resistance could be useful to prevent detrimental effects of compromised tissue perfusion, especially in high-risk surgical patients.

The primary objective of the study is to compare two strategies of intraoperative blood pressure management in high-risk surgical patients: 1- Continuous infusion of noradrenaline to maintain arterial blood pressure of no more than 10% below its baseline value; 2- Conventional treatment of hypotension (defined as a blood pressure of below 80 mmHg or a decrease of more than 40% from baseline) using intravenous bolus of Ephedrine chorhydrate.

The investigators hypothesis is that maintenance of arterial blood pressure with noradrenaline could reduce postoperative organ dysfunction in high-risk surgical patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥ 50 years
  • •ASA score ≥ 2
  • •Planned and unplanned surgical procedures
  • •Abdominal, orthopaedic and vascular surgery
  • •Expected duration ≥ 2 hours
  • •AKI risk index ≥ class 3

排除标准

  • •Severe preoperative hypertension (not controlled)
  • •Creatinine clearance < 30 ml/min or preoperative dialysis
  • •Acute cardiac failure
  • •Preoperative sepsis
  • •Preoperative hemodynamic failure (shock)
  • •Intraoperative use of locoregional anaesthesia (epidural and spinal)
  • •Patient refusal
  • •Pregnancy and/or lactation

研究组 & 干预措施

Noradrenaline

Experimental

Continuous infusion of noradrenaline to maintain arterial blood pressure management in high-risk surgical patients

干预措施: noradrenaline (Other)

Ephedrine chorhydrate

Experimental

Conventional treatment of hypotension (defined as a blood pressure of below 80 mmHg or a decrease of more than 40% from baseline)using intravenous bolus of Ephedrine chorhydrate

干预措施: Ephedryne chorydrate (Other)

结局指标

主要结局

Composite endpoint of postoperative SIRS and at least one major organ dysfunction

时间窗: day-7

次要结局

  • Intraoperative blood losses(at day 7)
  • Need for intraoperative transfusion(at day 7)
  • Incidence of intraoperative bradycardia(at day 7)
  • Postoperative organ failure(at day 7)
  • Incidence of intraoperative hypotension(at day 7)
  • Incidence of intraoperative hypertension(at day 7)
  • Intraoperative volume of fluid perfused(at day 7)
  • Biologic criteria: plasma concentration of NGAL, creatinine, CRP, serum lactate, troponine)(at day 7)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验